• Register
  • Login
  • Subscribe
  • Contact Us

Identification and Referral Service of Vhrw Following Radiotherapy

GreatbritainTenders notice for Identification and Referral Service of Vhrw Following Radiotherapy. The reference ID of the tender is 110100757 and it is closing on 04 Dec 2024.

Tender Details

  • Country: United Kingdom
  • Summary: Identification and Referral Service of Vhrw Following Radiotherapy
  • GBT Ref No: 110100757
  • Deadline: 04 Dec 2024
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: CF-2705700D0O000000rwimUAA
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • NHS England is to conduct market engagement to obtain input and feedback in preparation for a potential Identification and Referral Service of Very High Risk Women Following Radiotherapy.
    The VHR cohort are currently identified and referred into the NHS Breast Screening Programme via clinical genetics services, clinical oncologists, and the service commissioned by NHS England from the Breast screening After Radiotherapy Dataset Group (BARD).
    Patients cured of a first cancer at a young age are at an increased risk of developing a second primary breast cancer. This is demonstrated in female survivors of Hodgkin Lymphoma (HL) and Non-Hodgkin Lymphoma (NHL) who received radiotherapy to breast tissue under the age of 36 and whose subsequent risk of breast cancer is raised.
    There will be a small number of women who have received radiotherapy to breast tissue as part of a treatment plan for diagnoses other than lymphoma. Current national guidelines recommend that screening should start 8 years after radiotherapy to breast tissue or at age 25 or 30 (depending on circumstances), whichever occurs later.
    In 2022/23, 10,493 women were screened within the NHSBSP VHR pathway.
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Identification and Referral Service of Vhrw Following Radiotherapy - Greatbritain Tender

The NHS ENGLAND, a Government sector organization in United Kingdom, has announced a new tender for Identification and Referral Service of Vhrw Following Radiotherapy. This tender is published on GreatbritainTenders under GBT Ref No: 110100757 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-12-04.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

GreatbritainTenders Features

GreatbritainTenders Features

Fresh and verified Tenders from Greatbritain. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting GreatbritainTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Greatbritain in your email inbox.

  Chat with us